NCT06234423
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06234423
Title A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors OnCusp Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE RECRUITING Denver Colorado 80218 United States Details
Yale University RECRUITING New Haven Connecticut 06520 United States Details
Mount Sinai Medical Center RECRUITING Miami Beach Florida 33140 United States Details
Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02115 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
NYU Cancer Institute Clinical Cancer Center RECRUITING New York New York 10016 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10021 United States Details
Stephenson Cancer Center RECRUITING Oklahoma City Oklahoma 73104 United States Details
SCRI Oncology Partners RECRUITING Nashville Tennessee 37203 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
NEXT Oncology RECRUITING Houston Texas 77054 United States Details
START San Antonio RECRUITING San Antonio Texas 78229 United States Details
NEXT Oncology RECRUITING Fairfax Virginia 22031 United States Details
Mater Cancer Care Centre RECRUITING South Brisbane Queensland 4101 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field